# Letter to the editor regarding ‘Performance of novel biomarkers for prediction of diabetic kidney disease in patients with diabetes mellitus’

**Authors:** Kaiyang Xu, Yutong Qian, Chen Zhao

PMC · DOI: 10.1080/07853890.2026.2612781 · Annals of Medicine · 2026-01-21

## Full-text entities

- **Genes:** CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, FGF23 (fibroblast growth factor 23) [NCBI Gene 8074] {aka ADHR, FGFN, HFTC2, HPDR2, HYPF, PHPTC}, GDF15 (growth differentiation factor 15) [NCBI Gene 9518] {aka GDF-15, HG, MIC-1, MIC1, NAG-1, PDF}, ANGPTL4 (angiopoietin like 4) [NCBI Gene 51129] {aka ARP4, FIAF, HARP, HFARP, NL2, PGAR}
- **Diseases:** diabetes mellitus (MESH:D003920), DM (MESH:D009223), DKD (MESH:D003928)
- **Chemicals:** RAS inhibitors (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12825648/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12825648/full.md

---
Source: https://tomesphere.com/paper/PMC12825648